Enhancing Heat Resiliency in Older Adults During Indoor Overheating Via Heat Acclimation by Warm Water Immersion
Evaluating the Efficacy of Heat Acclimation by Warm Water Immersion for Mitigating Hyperthermia and Cardiovascular Demand in Older Adults During Indoor Overheating.
1 other identifier
interventional
12
1 country
1
Brief Summary
As overheating in buildings is expected to increase as global warming continues, proactive measures to increase heat resiliency in heat-vulnerable older people are needed, especially for those without access to home cooling or reliable sources of electricity. While short-term heat acclimation through exercise in the heat has been shown to increase heat dissipation and decrease both the physical and mental stress imposed on individuals exposed to heat, such protocols are not tenable for older, sedentary adults. A recent report showed that seven consecutive days of warm-water immersion improved whole-body heat loss and reduced physiological strain as assessed during an exercise-heat stress in habitually active older men This represents a critical finding as an increase heat-loss capacity would serve as an important safeguard for older adults exposed to indoor overheating due to lack of air-conditioning. While this preliminary data highlights passive hot water immersion as a promising strategy for increasing heat-resilience in vulnerable adults, work is needed to confirm its efficacy in more "real-world" environments. Thus, this study aims to assess the effectiveness of a 7-day passive heating (warm-water immersion with core temperature clamped at \~38.5°C for the final 60 minutes) protocol in mitigating increases in thermal and cardiovascular strain in older females exposed to daylong (10-hours) indoor overheating (36°C, 45% relative humidity) prior to and following the passive heating intervention. Relative to males, females have a reduced heat loss capacity (\~5%), which is driven by differences in the activation of heat loss responses (i.e., skin blood flow and sweating). Although there have been mixed findings with regards to the influence of sex as a mediating factor for heat-related mortality, some studies suggest that females are at a higher risk of heat-related mortality and morbidity compared to males, especially amongst older individuals (≥65 years). Notably, a greater proportion of older females died compared to their male counterparts during the 2021 Western Heat Dome. While the underlying causes for these differences remain unclear, greater cardiovascular strain may place females at higher mortality risk during extreme heat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2024
CompletedFirst Posted
Study publicly available on registry
November 1, 2024
CompletedStudy Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJune 15, 2025
June 1, 2025
1.1 years
October 29, 2024
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (25)
Core temperature (Peak) during daylong heat exposure
Peak rectal temperature (15 min average) during exposure. Rectal temperature is measured continuously throughout the 10 hours of the simulated heat wave performed prior to and following the 7-day heat acclimation by warm-water immersion.
End of 10 hour daylong heat exposure
Core temperature (AUC) during daylong heat exposure
Area under the curve (AUC) of rectal temperature (in degree-hours) during the 10 hour simulated heat wave exposure performed prior to and following the 7-day heat acclimation by warm-water immersion.
End of 10 hour daylong heat exposure
Heat rate (Peak) during daylong heat exposure
Peak Heart rate (15-min average) during the 10 hour simulated heat wave exposure performed prior to and following the 7-day heat acclimation by warm-water immersion.
End of 10 hour daylong heat exposure
Heat rate (AUC) during daylong heat exposure
Area under the curve (AUC) of heart rate during the 10 hour simulated heat wave exposure performed prior to and following the 7-day heat acclimation by warm-water immersion.
End of 10 hour daylong heat exposure
Cardiac response to standing from supine (30:15 Ratio) during daylong heat exposure
Cardiac response to standing evaluated as the ratio between the highest R-wave to R-wave interval (lowest heart rate) measured at the 30th heart beat after standing from supine (+/- 5 beats) and the lowest R-wave to R-wave interval (highest heart rate) measured at the 15th heart beat after standing (+/- 5 beats). Cardiac response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).
At the start (hour 0) and end of daylong heat exposure (hour 10)
Systolic Response to Standing From Supine during daylong heat exposure
Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest). Assessed at the start and end of the 10 hour simulated heat wave exposure performed prior to and following the 7-day heat acclimation by warm-water immersion.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Heart rate variability: RMSSD during daylong heat exposure
Root mean squared standard deviation of normal-to-normal R-wave to R-wave intervals (RMSSD) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. RMSSD will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Heart rate variability: SDNN during daylong heat exposure
Standard deviation of normal-to-normal R-wave to R-wave intervals (SDNN) measured during 5 minutes of paced breathing (15 breaths/min) with participants in the supine position. SDNN will be evaluated twice, during two paced breathing periods (separated by 4 min of supine rest).
At the start (hour 0) and end of daylong heat exposure (hour 10)
Thermal comfort scale during daylong heat exposure
Thermal comfort assessed via a visual analog scale ranging from extremely uncomfortable to extremely comfortable (midpoint: neutral).
End of 10 hour daylong heat exposure
Thirst sensation scale during daylong heat exposure
Thirst sensation scale assessed via a visual analog scale (9: very, very thirsty to 1: Not thirsty at all)
End of 10 hour daylong heat exposure
Thermal sensation scale during daylong heat exposure
Thermal sensation assessed via a visual analog scale ranging from extremely hot to neutral (midpoint: hot).
End of 10 hour daylong heat exposure
Arousal scale during daylong heat exposure
Felt arousal scale assessed via a visual analog scale ("How worked up are you?") ranging from "high arousal" to "low arousal".
End of 10 hour daylong heat exposure
Fluid loss during daylong heat exposure
Body fluid loss calculated as a change in body weight from pre-exposure values (corrected for food intake and deification).
End of 10 hour daylong heat exposure
Fluid consumption during daylong heat exposure
Average hourly fluid consumption calculated by weighing participant water intake at the start and end of each hour of exposure (normalized to the exposure duration).
End of 10 hour daylong heat exposure
Changes in plasma volume during daylong heat exposure
Change in plasma volume from baseline values calculated from duplicate measurements of hemoglobin and hematocrit at the start and end of each exposure using the technique by Dill and Costill
End of 10 hour daylong heat exposure
Systolic blood pressure during daylong heat exposure
Systolic blood pressure measured in triplicate via automated oscillometry (\~60 seconds between measures)
End of 10 hour daylong heat exposure
Diastolic blood pressure during daylong heat exposure
Diastolic blood pressure measured in triplicate via automated oscillometry (\~60 seconds between measures)
End of 10 hour daylong heat exposure
Systolic Response to Standing From Supine during daylong heat exposure
Systolic blood pressure response to standing evaluated as the difference in blood pressure measured between the standing and supine. Standing systolic blood pressure will be taken as the lowest value of those measured after 60 and 120 seconds of standing. Systolic response to standing will be evaluated twice, during two lying-to-standing tests (separated by 10 min of supine rest).
End of 10 hour daylong heat exposure
Rate pressure product during daylong heat exposure
Rate pressure product, an index of myocardial work and strain, calculated as systolic blood pressure x heart rate.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Orthostatic intolerance symptoms assessment during daylong heat exposure
Cumulative sum of scores on 6 questions asking participant to rank symptoms associated with orthostatic intolerance during the lying to standing tests. All symptoms scored on a scale from 0 (none) to 10 (worst possible) and include feelings of: (1) "dizziness, lightheadedness, feeling faint, or feeling like you might black out"; (2) "Problems with vision (blurring, seeing spots, tunnel vision, etc.)"; (3) "Weakness"; (4) "Fatigue"; (5) "Trouble concentrating"; and (6) "Head and neck discomfort".
End of 10 hour daylong heat exposure
Reaction time (cognitive function) during daylong heat exposure
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of reaction time. Participants will be asked to initiate a movement of the device in response to a visual cue.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Impulse control (cognitive function) during daylong heat exposure
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of impulse control. Participants will be asked to respond to both "go" and "no-go" visual cues. In response to the "go" cue, participants will initiate a movement of the device.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Memory recall (cognitive function) during daylong heat exposure
Participants will be provided with a tablet device with the Sway Medical testing platform for the assessment of memory recall. Participants complete both a delayed recall test and a working memory test.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
CDC 4-Stage Balance Test (Postural stability) during daylong heat exposure
To assess postural stability, participants hold a tablet to their chest, then auditory cues guide participants through four consecutive stances, feet side by side, instep of one foot touching the big toe of the other foot, tandem stand with one foot in front of the other, heel touching toe, and stand on one foot. The balance assessment will be evaluated based on movement detected by an accelerometer integrated into the hardware of the tablet device (Sway Medical Inc).
At the start (hour 0) and end of the daylong heat exposure (hour 10)
BTrackS Balance Assessment (Postural stability) during daylong heat exposure
To assess postural stability, participants will be asked to stand on a BTracks force plate with their feet spread out to shoulder width, hand on their hips and eyes closed. The assessment will comprise of four trials (one practice trial) lasting 20 seconds in length and 20 seconds between trials. Center of pressure (COP) vector data along vertical (y) and horizontal (x) axes will be summed for the total path excursion length (cm) during each trial.
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Secondary Outcomes (5)
Muscle oxygen during battery of cardiovascular, cognition and postural stability tests during daylong heat exposure
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Profiles of Mood States (POMS) during daylong heat exposure
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Environmental Symptoms Questionnaire (ESQ)
At the start (hour 0) and end of the daylong heat exposure (hour 10)
Sleepiness during daylong heat exposure A
End of 10 hour daylong heat exposure
Sleepiness during daylong heat exposure B
End of 10 hour daylong heat exposure
Study Arms (1)
Daylong exposure to indoor overheating
EXPERIMENTALPrior to and following the warm-water immersion protocol, participants will undergo a 10-hour passive heat exposure where they will remain in a climate-controlled chamber regulated at 36°C and 45% humidity (temperatures experienced indoors during extreme heat events in North America). During this time they will remain seated with the exception of hourly 5-minute breaks to stretch.
Interventions
Participants will be immersed in a whirlpool tub to the shoulder level in a circulated water bath maintained at \~40°C until their core temperature achieves a steady-state of 38.5°C for 60 minutes. The warm-water immersion protocol will be repeated for 6 more consecutive days.
Eligibility Criteria
You may qualify if:
- Non-smoking.
- English or French speaking.
- Ability to provide informed consent.
- With or without a) chronic hypertension (elevated resting blood pressure; as defined by Heart and Stroke Canada and Hypertension Canada), b) type 2 diabetes as defined by Diabetes Canada, with at least 5 years having elapsed since time of diagnosis
You may not qualify if:
- Episode(s) of severe hypoglycemia (requiring the assistance of another person) within the previous year, or inability to sense hypoglycemia (hypoglycemia unawareness).
- Serious complications related to your diabetes (gastroparesis, renal disease, uncontrolled hypertension, severe autonomic neuropathy).
- Uncontrolled hypertension - BP \>150 mmHg systolic or \>95 mmHg diastolic in a sitting position.
- Restrictions in physical activity due to disease (e.g. intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
- Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable.
- Cardiac abnormalities identified during screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Ottawa
Ottawa, Ontario, K1N1A2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glen P Kenny, PhD
University of Ottawa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 29, 2024
First Posted
November 1, 2024
Study Start
November 11, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
June 15, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- Following publication of the main study report(s)
- Access Criteria
- Approved analysis plan and signed access agreement
Deidentified participant data will be made available with approved analysis plan and signed access agreement